Menu
Not yet recruiting NCT07575074

OKT With Gaze and Postural Stabilization on Vertigo, MS and QOL in VBH

No phase Interventional Vestibular Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Group A Habituation exercises, Group B Optokinetic training protocol.
Who it may be relevant to
Registry conditions: Vestibular Disorder. Basic parameters: 20 years — 40 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Effects of Optokinetic Training With Gaze and Postural Stabilization on Vertigo, Motion Sickness and Quality of Life in Vestibular Hypofunction

Overview

The objective of this study will evaluate the effects of optokinetic training combined with postural stabilization and gaze stability exercises on motion sickness, balance, gaze stability, and quality of life in individuals with vestibular hypofunction.

Detailed description

A randomized clinical trial will be conducted with 32 participants assigned to two groups: Group A (breathing and aerobic exercises) and Group B (optokinetic training combined with postural stabilization and gaze stability exercises). Data will be collected using the Motion Sickness Susceptibility Questionnaire (MSSQ), Berg Balance Scale (BBS), Dynamic Visual Acuity Test for Gaze Stability, and Head Impulse Test. Statistical analysis will be performed by SPSS.

Interventions

  • Other Group A Habituation exercises
    Habituation exercises five times per week to improve overall wellness and reduce baseline symptoms of motion sickness (38). Each session, lasting approximately 20-25 minutes, involved exercises conducted for 20 minutes per day, five times a week. Each session, lasting approximately 30-45 minutes, included low-intensity breathing exercises aimed at promoting relaxation and moderate-intensity aerobic activities, such as walking or cycling, at 50-60% of the participant's maximum heart rate.
  • Other Group B Optokinetic training protocol
    10-minute warm-up, followed by 20-25 minutes of moderate-intensity optokinetic exercises (viewing controlled moving visual patterns), postural exercises involving controlled head and body movements to engage the vestibular system, and gaze stability exercises, which require focusing on a stationary target during head movements to improve the vestibulo-ocular reflex. The session concluded with a 10-15-minute cool-down to aid relaxation. These sessions continued for 12 weeks

Primary outcome measures

  • Motion sickness susceptibility questionnaire [Time frame: 8th week]
  • Berg balance scale [Time frame: 8th week]
  • Dynamic visual acuity test for gaze stability [Time frame: 8th week]
  • Head impulse test [Time frame: 8th week]

Eligibility criteria

Inclusion criteria

  • • Male and female patients age 20 and 40 years
  • Passengers who have motion sickness during travelling
  • Patients of vestibular migraine who experience motion sickness
  • Participants experiencing vertigo, dizziness or imbalance related to vestibular hypofunction over the past three months

Exclusion criteria

  • • Patients who have seasickness and simulator sickness excluded.
  • Patients having vestibular disease and chronic neurological disease.
  • Participants who have completed formal vestibular rehabilitation in last 6 months excluded
  • Patients with severe visual impairments and orthopedic conditions excluded.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Pakistan · 1 center
  • Ittefaq Hospital Lahore — Lahore

Identifiers

NCT: NCT07575074 · REC/RCR & AHS/24/02100

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗